Home/Filings/4/0001415889-24-024452
4//SEC Filing

Alpern Robert J 4

Accession 0001415889-24-024452

CIK 0001551152other

Filed

Oct 1, 8:00 PM ET

Accepted

Oct 2, 5:00 PM ET

Size

5.9 KB

Accession

0001415889-24-024452

Insider Transaction Report

Form 4
Period: 2024-09-30
Transactions
  • Award

    Stock Equivalent Units

    2024-09-30$197.48/sh+37$7,3079,655 total
    Exercise: $197.48Common Stock (37 underlying)
Footnotes (2)
  • [F1]Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock.
  • [F2]Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.

Issuer

AbbVie Inc.

CIK 0001551152

Entity typeother

Related Parties

1
  • filerCIK 0001448074

Filing Metadata

Form type
4
Filed
Oct 1, 8:00 PM ET
Accepted
Oct 2, 5:00 PM ET
Size
5.9 KB